Vir Biotechnology, Bank of America Securities
Digest more
Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and how to wisely invest in this innovative field.
Biotech ETFs can help investors capitalize on health care innovation while avoiding the boom-or-bust nature of individual firms.
Andrew Hillman Grant for Biotech Introduces National Opportunity for Undergraduate Talent to Explore the Future of
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at
Fermentation has evolved from a traditional preservation method into a cornerstone of modern food innovation, where the intersection of bioprocess
BioDuro has entered a strategic partnership with CTI Biotechnology to build an integrated preclinical development platform spanning drug discovery through to investigational new drug submission.
Vir Biotechnology Reports Positive Updated Phase 1 Results for PSMA-targeting, PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer – Updated Phase 1 dose-escalation data (n=58) show VIR-5500 monotherapy has a ...
The biotech group has struggled as a whole in 2025, but analysts say the innovation that has always supported the biotech industry is alive and well. Here are seven top biotech stocks with "overweight" ratings from Morgan Stanley analysts:
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s ...
Odyssey Therapeutics Inc., a clinical stage biotechnology firm focused on autoimmune and inflammatory diseases, is seeking to raise $238.3 million in an initial public offering.